He points out that losartan is alone among ARBs in the US in being available as a generic and therefore is cheaper to use than
candesartan (another ARB, valsartan [Diovan, Novartis], is set to go off patent later this year.) "That means a lot of physicians are using it to save on the cost of medications. So I think that it's a worthwhile point to make that the drug simply requires at least a 100-mg initial dose and consideration of twice-daily dosing rather than once a day.